Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

The Identification and Characterization of Retrospective Cohorts of Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Patients in the United States

Catherine Broome, Joseph Patrick Catlett, Daniel J Hausrath, Rahul Shah, Jacob Lai, Kathy Dong, Jon Fryzek, Meghan Mitchell, Lauren Bylsma, Loren Lipworth, Todd Edwards, Nawar Shara, Stephen Fernandez, Naval Daver, Carl E Allen

Blood (2023) 142 (Supplement 1): 5357.

https://doi.org/10.1182/blood-2023-180249

Published: 2023

Journal Articles

Initial Report of Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Autoimmune Cytopenias: The RUBY-4 Study

Catherine Broome, David J Kuter, Keith R. McCrae, Rupert Davies, Amanda Enstrom, Allison Chunyk, Heather Thomas, Allison Naumovski, Steven R. Lentz

Blood (2023) 142 (Supplement 1): 5520.

https://doi.org/10.1182/blood-2023-179305

Published: 2023

Journal Articles

Incidence and Management of COVID-19 Infections in Vaccinated Patients with CLL

Blood (2023) 142 (Supplement 1): 5149.

https://doi.org/10.1182/blood-2023-173992

Published: 2023

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

David J. Kuter, MD DPhil, Richy Agajanian, MD, Donald M. Arnold, MD MSc, FRCPC, Michael Boxer, MD, Catherine Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Kerry A. Rogers, MD, Ann M Lowe, MD, Sandra Tong, MD, Hany Zayed, PhD, Anne-Marie Duliege, MD MS

Blood (2018) 132 (Supplement 1): 3612.

https://doi.org/10.1182/blood-2018-99-110483

Published: 2018

Journal Articles

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of HLA Mismatched Platelets in a Transfusion Refractory Alloimmunized Patient: A Case Report

Maryam Sarraf Yazdy, MD, Catherine Broome, MD

Blood (2017) 130 (Supplement 1): 4845.

https://doi.org/10.1182/blood.V130.Suppl_1.4845.4845

Published: 2017

Journal Articles

Incidence of Thromboembolic Events Is Increased in a Retrospective Analysis of a Large Cold Agglutinin Disease (CAD) Cohort

Catherine Broome, MD, Julia M Cunningham, MD, Megan Mullins, MPH, Xiaohui Jiang, MS, Lauren Bylsma, MPH, Jon Fryzek, MPH, PhD, Adam Rosenthal, PhD

Blood (2017) 130 (Supplement 1): 928.

https://doi.org/10.1182/blood.V130.Suppl_1.928.928

Published: 2017

Journal Articles

Outcomes for Atypical Hemolytic Uremic Syndrome (aHUS) Treated with Eculizumab: A Single Center Analysis

Julia M Cunningham, MD, Jaeil Ahn, PhD, Catherine Broome, MD

Blood (2017) 130 (Supplement 1): 2331.

https://doi.org/10.1182/blood.V130.Suppl_1.2331.2331

Published: 2017

Journal Articles

Relapsing Thrombotic Thrombocytopenic Purpura: A Single Center Experience

Arielle L Heeke, MD, Craig M. Kessler, MD, Catherine Broome, MD

Blood (2016) 128 (22): 3732.

https://doi.org/10.1182/blood.V128.22.3732.3732

Published: 2016

Journal Articles

Management of Catastrophic Antiphosphopholipid Syndrome with Eculizumab

Ami Chitalia, MD, David Swoboda, MD, Catherine Broome, MD

Blood (2016) 128 (22): 2603.

https://doi.org/10.1182/blood.V128.22.2603.2603

Published: 2016

Journal Articles

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of Antigen Mismatched Packed Red Blood Cells : A Case Report

Eiran Warner, MD BA, Catherine Broome, MD

Blood (2016) 128 (22): 3843.

https://doi.org/10.1182/blood.V128.22.3843.3843

Published: 2016

Journal Articles

A Case Series of Non-Hodgkin's Lymphoma Recurrence in Lower Extremities Mimicking Deep Vein Thrombosis

Shelly Ann Christiansen, MD, Philip Cohen, MD, Catherine Broome, MD

Blood (2016) 128 (22): 5344.

https://doi.org/10.1182/blood.V128.22.5344.5344

Published: 2016

Journal Articles

Complement Blockade with C1 Esterase Inhibitor in Severe C3d Positive Autoimmune Hemolytic Anemia

Jasmin Desai, MD, Catherine Broome, MD

Blood (2016) 128 (22): 4817.

https://doi.org/10.1182/blood.V128.22.4817.4817

Published: 2016

Journal Articles

Presentation and Time to Treatment of Atypical Hemolytic Uremic Syndrome Is Influenced By Complement Amplifying Conditions: A Single Center Experience

Julia M Cunningham, MD, Jimmy Wang, PhD, Catherine Broome, MD

Blood (2016) 128 (22): 2543.

https://doi.org/10.1182/blood.V128.22.2543.2543

Published: 2016

Journal Articles

Complement Regulatory Gene Mutations in Non-Renal Solid Organ Transplant Recipients with Post-Transplant Thrombotic Microangiopathy

Kruti Sheth, MD, Raffaele Girlanda, MD, Catherine Broome, MD

Blood (2015) 126 (23): 3463.

https://doi.org/10.1182/blood.V126.23.3463.3463

Published: 2015

Journal Articles

Long-Term Management of Atypical Hemolytic Uremic Syndrome after Non-Renal Solid Organ Transplantation with Eculizumab

Kruti Sheth, MD, Raffaele Girlanda, MD, Catherine Broome, MD

Blood (2015) 126 (23): 3466.

https://doi.org/10.1182/blood.V126.23.3466.3466

Published: 2015

Journal Articles

Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia

Erin Elizabeth Roesch, MD, Catherine Broome, MD

Blood (2015) 126 (23): 2253.

https://doi.org/10.1182/blood.V126.23.2253.2253

Published: 2015

Journal Articles

Eculizumab Reduces Red Blood Cell Transfusions in Non-Renal Solid Organ Transplant Patients Diagnosed with Post Transplant Atypical Hemolytic Uremic Syndrome (PT-aHUS)

Catherine Broome, MD, Raffaele Girlanda, MD, S. Gerald Sandler, MD

Blood (2014) 124 (21): 4183.

https://doi.org/10.1182/blood.V124.21.4183.4183

Published: 2014

Journal Articles

Identifying Post Transplant Atypical Hemolytic Uremic Syndrome in Small Bowel Transplant Patients: A Retrospective Analysis

Kruti Sheth, MD, Daniel Smith, MD, Raffaele Girlanda, MD, Catherine Broome, MD

Blood (2014) 124 (21): 4212.

https://doi.org/10.1182/blood.V124.21.4212.4212

Published: 2014

Journal Articles

Successful Management Of Calcineurin Induced Thrombotic Microangiopathy(TMA) With Eculizumab After Non- Renal Solid Organ Transplantation

Catherine Broome, MD, James K. McCloskey, MD, Raffaele Girlanda, MD

Blood (2013) 122 (21): 1078.

https://doi.org/10.1182/blood.V122.21.1078.1078

Published: 2013

Journal Articles

Lenalidomide Following Rituximab and Fludarabine in Untreated CLL

Chaitra S. Ujjani, MD, Edmund Gehan, PhD, Saad Jamshed, MD, Jeanette Crawford, Catherine Broome, MD, Philip Cohen, MD, Bruce D. Cheson, MD

Blood (2012) 120 (21): 3924.

https://doi.org/10.1182/blood.V120.21.3924.3924

Published: 2012

NARROW

The Identification and Characterization of Retrospective Cohorts of Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Patients in the United States

Initial Report of Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Autoimmune Cytopenias: The RUBY-4 Study

Incidence and Management of COVID-19 Infections in Vaccinated Patients with CLL

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of HLA Mismatched Platelets in a Transfusion Refractory Alloimmunized Patient: A Case Report

Incidence of Thromboembolic Events Is Increased in a Retrospective Analysis of a Large Cold Agglutinin Disease (CAD) Cohort

Outcomes for Atypical Hemolytic Uremic Syndrome (aHUS) Treated with Eculizumab: A Single Center Analysis

Relapsing Thrombotic Thrombocytopenic Purpura: A Single Center Experience

Management of Catastrophic Antiphosphopholipid Syndrome with Eculizumab

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of Antigen Mismatched Packed Red Blood Cells : A Case Report

A Case Series of Non-Hodgkin's Lymphoma Recurrence in Lower Extremities Mimicking Deep Vein Thrombosis

Complement Blockade with C1 Esterase Inhibitor in Severe C3d Positive Autoimmune Hemolytic Anemia

Presentation and Time to Treatment of Atypical Hemolytic Uremic Syndrome Is Influenced By Complement Amplifying Conditions: A Single Center Experience

Complement Regulatory Gene Mutations in Non-Renal Solid Organ Transplant Recipients with Post-Transplant Thrombotic Microangiopathy

Long-Term Management of Atypical Hemolytic Uremic Syndrome after Non-Renal Solid Organ Transplantation with Eculizumab

Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia

Eculizumab Reduces Red Blood Cell Transfusions in Non-Renal Solid Organ Transplant Patients Diagnosed with Post Transplant Atypical Hemolytic Uremic Syndrome (PT-aHUS)

Identifying Post Transplant Atypical Hemolytic Uremic Syndrome in Small Bowel Transplant Patients: A Retrospective Analysis

Successful Management Of Calcineurin Induced Thrombotic Microangiopathy(TMA) With Eculizumab After Non- Renal Solid Organ Transplantation

Lenalidomide Following Rituximab and Fludarabine in Untreated CLL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only